ik-930
ikena oncology
['ik-930', '$ikna', 'ikena ']
$ikna ikena oncology shares differentiation profile of ik-930, a novel hippo-pathway inhibitor, including projected therapeutic index advantages and breadth of patient populations at aacr 2023 annual meeting #investing
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i